Mascoma Wealth Management’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-40
Closed -$4.8K 462
2025
Q2
$4.8K Hold
40
﹤0.01% 383
2025
Q1
$5.89K Hold
40
﹤0.01% 382
2024
Q4
$6.5K Hold
40
﹤0.01% 383
2024
Q3
$6.52K Hold
40
﹤0.01% 364
2024
Q2
$5.46K Hold
40
﹤0.01% 401
2024
Q1
$6.12K Hold
40
﹤0.01% 364
2023
Q4
$5.7K Hold
40
﹤0.01% 378
2023
Q3
$5.24K Hold
40
﹤0.01% 388
2023
Q2
$6.48K Sell
40
-25
-38% -$4.03K ﹤0.01% 364
2023
Q1
$10.8K Sell
65
-8
-11% -$1.2K ﹤0.01% 398
2022
Q4
$10.2K Buy
73
+8
+12% +$1.14K ﹤0.01% 407
2022
Q3
$8K Hold
65
﹤0.01% 424
2022
Q2
$9K Hold
65
﹤0.01% 428
2022
Q1
$9K Hold
65
﹤0.01% 451
2021
Q4
$11K Hold
65
﹤0.01% 394
2021
Q3
$11K Buy
+65
New +$11.2K ﹤0.01% 338
2018
Q4
Sell
-866
Closed -$130K 375
2018
Q3
$130K Hold
866
0.09% 101
2018
Q2
$117K Hold
866
0.08% 98
2018
Q1
$115K Hold
866
0.08% 102
2017
Q4
$113K Hold
866
0.07% 102
2017
Q3
$114K Hold
866
0.08% 103
2017
Q2
$115K Hold
866
0.08% 104
2017
Q1
$117K Hold
866
0.08% 91
2016
Q4
$104K Buy
+866
New +$102K 0.08% 102

Other funds holding CLX

Mascoma Wealth Management's CLX Position: Q3 2025 in Review

Mascoma Wealth Management sold out of Clorox (CLX) in Q3 2025, closing a stake of 40 shares — an estimated $4.8K sold.

Mascoma Wealth Management first reported a position in CLX in Q4 2016 and held it in 24 quarters. The position peaked at $130K in Q3 2018. 1,093 funds tracked by Wall St. Rank hold CLX as of Q3 2025.

  • Mascoma Wealth Management reported no remaining Clorox position as of Q3 2025 after selling out during the quarter.
  • Mascoma Wealth Management sold 40 Clorox shares in Q3 2025, an estimated $4.8K.
  • Mascoma Wealth Management first reported a position in Clorox in Q4 2016 and held it in 24 quarters.
  • Mascoma Wealth Management's Clorox position peaked at $130K in Q3 2018.
  • 1,093 funds tracked by Wall St. Rank held Clorox as of Q3 2025.

Based on Mascoma Wealth Management's 13F filing for Q3 2025, filed 28 Oct 2025.